The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
A new Formula 1 season is underway. Lando Norris made the perfect start to his title challenge in Australia as he looks to dethrone reigning champion Max Verstappen. We have now entered the first ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
THE WEEK’S MOST POPULAR CURRENT R&B SONGS ACROSS ALL GENRES, RANKED BY STREAMING ACTIVITY DATA BY ONLINE MUSIC SOURCES TRACKED BY LUMINATE, RADIO AIRPLAY AUDIENCE IMPRESSIONS AS MEASURED BY ...
THE WEEK’S MOST POPULAR CURRENT R&B/HIP-HOP SONGS ACROSS ALL GENRES, RANKED BY STREAMING ACTIVITY DATA BY ONLINE MUSIC SOURCES TRACKED BY LUMINATE, RADIO AIRPLAY AUDIENCE IMPRESSIONS AS MEASURED ...
After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...
Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback